Imai T - Search Results

1

Lifelong Heterogeneous Contribution of Cardiovascular Risk Factors to Slow and Fast Progression of Arterial Stiffness.

Tomiyama H, Imai T, Shiina K, Higashi Y, Nakano H, Takahashi T, Fujii M, Matsumoto C, Yamashina A, Chikamori T. Tomiyama H, et al. Among authors: imai t. Hypertension. 2023 Oct;80(10):2159-2168. doi: 10.1161/HYPERTENSIONAHA.123.21481. Epub 2023 Aug 8. Hypertension. 2023. PMID: 37551598 Free article.

2

Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents.

Tanaka A, Toyoda S, Imai T, Shiina K, Tomiyama H, Matsuzawa Y, Okumura T, Kanzaki Y, Onishi K, Kiyosue A, Nishino M, Sakata Y, Node K; CANDLE trial investigators. Tanaka A, et al. Among authors: imai t. Cardiovasc Diabetol. 2021 Sep 3;20(1):175. doi: 10.1186/s12933-021-01369-5. Cardiovasc Diabetol. 2021. PMID: 34479543 Free PMC article. Clinical Trial.

3

Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial.

Kusunose K, Imai T, Tanaka A, Dohi K, Shiina K, Yamada T, Kida K, Eguchi K, Teragawa H, Takeishi Y, Ohte N, Yamada H, Sata M, Node K; CANDLE Trial Investigators. Kusunose K, et al. Among authors: imai t. Cardiovasc Diabetol. 2021 Sep 14;20(1):186. doi: 10.1186/s12933-021-01380-w. Cardiovasc Diabetol. 2021. PMID: 34521417 Free PMC article. Clinical Trial.

4

Canagliflozin independently reduced plasma volume from conventional diuretics in patients with type 2 diabetes and chronic heart failure: a subanalysis of the CANDLE trial.

Shiina K, Tomiyama H, Tanaka A, Imai T, Hisauchi I, Taguchi I, Sezai A, Toyoda S, Dohi K, Kamiya H, Kida K, Anzai T, Chikamori T, Node K; CANDLE trial investigators. Shiina K, et al. Among authors: imai t. Hypertens Res. 2023 Feb;46(2):495-506. doi: 10.1038/s41440-022-01085-x. Epub 2022 Nov 15. Hypertens Res. 2023. PMID: 36380202

5

Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study.

Kishimoto S, Higashi Y, Imai T, Eguchi K, Fukumoto K, Tomiyama H, Maemura K, Tanaka A, Node K; PROTECT investigators. Kishimoto S, et al. Among authors: imai t. Cardiovasc Diabetol. 2023 May 20;22(1):119. doi: 10.1186/s12933-023-01856-x. Cardiovasc Diabetol. 2023. PMID: 37210524 Free PMC article. Clinical Trial.

6

Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: insights from the randomized PROTECT trial.

Saito Y, Tanaka A, Imai T, Nakamura I, Kanda J, Matsuhisa M, Uehara H, Kario K, Kobayashi Y, Node K; PROTECT investigators. Saito Y, et al. Among authors: imai t. Hypertens Res. 2024 Jan;47(1):168-176. doi: 10.1038/s41440-023-01494-6. Epub 2023 Nov 14. Hypertens Res. 2024. PMID: 37964067 Clinical Trial.

7

Kurajoh M, Hiura Y, Numaguchi R, Ihara Y, Imai T, Morioka T, Emoto M, Nishiguchi Y. Kurajoh M, et al. Among authors: imai t. Biomedicines. 2023 Mar 10;11(3):854. doi: 10.3390/biomedicines11030854. Biomedicines. 2023. PMID: 36979833 Free PMC article.

8

Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non-severe coronavirus disease 2019.

Numaguchi R, Kurajoh M, Hiura Y, Imai T, Morioka T, Saito M, Shiraishi S, Emoto M, Nishiguchi Y. Numaguchi R, et al. Among authors: imai t. J Diabetes Investig. 2022 Oct;13(10):1779-1787. doi: 10.1111/jdi.13845. Epub 2022 Jun 9. J Diabetes Investig. 2022. PMID: 35616179 Free PMC article.

9

Complete Right Bundle Branch Block as a Predictor of Cardiovascular Events in Type 2 Diabetes.

Ono K, Uchimoto S, Miyazaki M, Honda N, Mori K, Morioka T, Imai T, Shoji T, Emoto M. Ono K, et al. Among authors: imai t. J Clin Med. 2022 Aug 8;11(15):4618. doi: 10.3390/jcm11154618. J Clin Med. 2022. PMID: 35956232 Free PMC article.

10

Reduced Risk of Progression from Non-Severe to Severe COVID-19 in Hospitalized Dialysis Patients by Full COVID-19 Vaccination.

Ichii M, Kurajoh M, Okute Y, Ihara Y, Imai T, Morioka T, Mori K, Shoji T, Tsujimoto Y, Ubai T, Emoto M. Ichii M, et al. Among authors: imai t. J Clin Med. 2022 Oct 27;11(21):6348. doi: 10.3390/jcm11216348. J Clin Med. 2022. PMID: 36362579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,212 results

Search Page